Advances and Challenges of Liposome Assisted Drug Delivery - Test2 - elhamkhani - TriplyDB

Advances and Challenges of Liposome Assisted Drug Delivery

Advances and Challenges of Liposome Assisted Drug Delivery

http://www.wikidata.org/entity/Q26773160

about

Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges Motif mediated protein-protein interactions as drug targets Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.Recent advances in light-responsive on-demand drug-delivery systems.Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy.Cryo-electron microscopy and cryo-electron tomography of nanoparticles.Radionuclide imaging of liposomal drug delivery.Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment.Design of Organic Macrocycle-Modified Iron Oxide Nanoparticles for Drug Delivery.Liposome-targeted delivery for highly potent drugs.Facilitating Translational Nanomedicine via Predictive Safety Assessment.TRAIL-NP hybrids for cancer therapy: a review.Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis In vitro synthesis of a Major Facilitator Transporter for specific active transport across Droplet Interface Bilayers.Comparison of the pharmacokinetic profiles of two different amphotericin B formulations in healthy dogs.Enhanced imaging of lipid rich nanoparticles embedded in methylcellulose films for transmission electron microscopy using mixtures of heavy metals.Newer drug delivery systems in anesthesia.Analyzing Liposomal Drug Delivery Systems in Three-Dimensional Cell Culture Models Using MALDI Imaging Mass Spectrometry Evidence of Protein Adsorption in Pegylated Liposomes: Influence of Liposomal Decoration.Evaluation of pharmacokinetic and pharmacodynamic profiles of liposomes for the cell type-specific delivery of small molecule drugs.Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies.Anticancer Activities of Surfactin and Potential Application of Nanotechnology Assisted Surfactin Delivery.High efficiency and long-term intracellular activity of an enzymatic nanofactory based on metal-organic frameworks.Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen species-independent apoptosis.Zeta potential: a case study of cationic, anionic, and neutral liposomes.Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy.Nanoparticle size and production efficiency are affected by the presence of fatty acids during albumin nanoparticle fabrication.Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.Recombinant Synthesis of Hybrid Lipid-Peptide Polymer Fusions that Self-Assemble and Encapsulate Hydrophobic Drugs.Engineering Polymersomes for Diagnostics and Therapy.Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.Internal Targeting and External Control: Phototriggered Targeting in Nanomedicine.Synovial fibroblast-targeting liposomes encapsulating an NF-κB-blocking peptide ameliorates zymosan-induced synovial inflammation.

P2860

Q26738338-288A51CE-1074-4DC4-997E-60ED88B7502B Q26740577-643330D1-8EA2-49A7-8111-69C2CE07A3E1 Q28079554-C23AC762-CDD7-46F4-ACEC-50DBCA4D3924 Q33710442-DDCB7180-17B3-4DAD-ABD2-615B5FC9E0DB Q37577552-D0E9E3DD-F99E-4E5C-B6F1-76006F044535 Q38693732-215F9118-F4D2-4EFC-BC61-29C84C109CC3 Q38770340-3DC6AA92-11A4-4E57-B401-275A18E685A9 Q38813380-F15A3902-055A-449F-9EB8-75F1D6C5AD7E Q38825691-5929DEA8-3812-465F-B460-30176A29344A Q38829320-98D36A79-16A2-4587-BCFE-597BC38C4A38 Q38856634-8F10ECE9-3963-482A-9A3A-8B1A76A8E5DD Q38875362-E3F8F5EF-9CAC-41BF-9BE4-549E4C2A6960 Q38879338-96644BC2-ACD9-49A1-A55A-BF1AE3DE2F0B Q39030222-F3972B73-21E8-4BF6-A781-4F711D7BF317 Q39121482-4650A3ED-12A1-4A86-8510-E95940F180ED Q39171223-3741FCBD-5967-4066-938D-A4559D363ABD Q39244552-3EFDF663-8F1B-436B-96D0-9D7A141E6E63 Q39263297-8343A7CC-7637-4869-ACCC-1B6A47D67BDD Q39370856-B5B2AD78-55A1-490D-A372-E225D2FA8179 Q39509928-DC91B124-F0E7-4C65-9A4C-5AF132546E15 Q40090449-FE587CCE-B468-47C0-BF55-5ED0B4C7A463 Q40238026-C37A26B4-D9B6-4BFA-AC4B-AC71E37DE96E Q41081606-B86F2EB3-1C71-4473-9898-E2CF094F242D Q41493074-C05724E0-CA5C-448B-96A8-0AC5A6056060 Q41598522-1DF7B75B-ECB2-4D89-9EEA-15BBE05D6C6B Q45064375-8C391580-30F4-4049-90F5-43768FD2624D Q45932069-69A23C34-81B0-4277-B22E-6524F4B79043 Q45988894-E8118F39-97B6-4CDC-879E-B19E8B5EFCBA Q46242635-B90B1992-A9DD-4DA2-980D-A48D0430D8A1 Q46252995-A3667FA0-210A-44AE-9528-0A3A777F58B2 Q46327978-651EBDF5-711F-4C7B-B088-61A270817416 Q47106467-818CF252-5D5A-44AD-A4C6-C897B7F0EF2E Q47172898-9EF9FACF-9A2B-4DAB-B1CB-B5139F9D78EE Q47190264-9C299BCE-44BD-46F2-BB24-768C45E45081 Q47324534-A22E9101-BBF7-4B16-A1D0-09E84182B5D8 Q47706872-783F34B3-72D3-4FE8-AD58-712906EC3A68 Q47732125-B61EC1FB-BB93-43A3-AE4A-59A81F14EF72 Q48029527-DB459CE9-2B1E-49F8-8EE6-B37CCE9F670A Q48122048-30B94931-B773-49F4-9DBD-6D1337D83F0E Q48136052-DB821F72-3B2A-4781-99C2-F89C59F45D97

P2860

Advances and Challenges of Liposome Assisted Drug Delivery

http://www.wikidata.org/entity/Q26773160

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Advances and Challenges of Liposome Assisted Drug Delivery

@ast

Advances and Challenges of Liposome Assisted Drug Delivery

@en

Advances and Challenges of Liposome Assisted Drug Delivery

@nl

type

label

Advances and Challenges of Liposome Assisted Drug Delivery

@ast

Advances and Challenges of Liposome Assisted Drug Delivery

@en

Advances and Challenges of Liposome Assisted Drug Delivery

@nl

prefLabel

Advances and Challenges of Liposome Assisted Drug Delivery

@ast

Advances and Challenges of Liposome Assisted Drug Delivery

@en

Advances and Challenges of Liposome Assisted Drug Delivery

@nl

P1433

Q26773160-28CD20F8-32E1-4CF4-9018-3060F0EBD67D

P1476

Q26773160-EC00238B-A428-4941-B1BB-C16673DD6961

P2093

Q26773160-314F24E0-07ED-4528-AA06-86017DB9A95F

Q26773160-3CDC7BBF-CDAE-47F0-94B1-2A0F67BCE19A

Q26773160-4B3FD5B1-687F-4A9A-94B3-5E258E9A1574

Q26773160-9A3061D2-9556-4BE8-B169-4645670AA9C9

Q26773160-F0C7472F-432D-4B3F-9C09-3B912DE4728A

P2860

Q26773160-002A87DF-316B-4BE0-928D-BE394CEEAF27

Q26773160-007F7F5D-CE2E-4577-A06C-7B9850E7BD16

Q26773160-01540B69-2811-4E9E-8232-B13D607DD693

Q26773160-035E9549-B4D2-41D0-91EF-F1F75B93D0D4

Q26773160-039AAC14-FB81-49AC-A1E7-81006FD0C92D

Q26773160-05F5FD0C-2EDB-4C54-95F0-6F427E7D024B

Q26773160-06D082EC-09FE-4930-8174-10CD235931B5

Q26773160-07C8C214-66DC-4D82-9F01-862700DE7BC4

Q26773160-0B11BDCB-57F5-4982-98BB-EC084AD3FF41

Q26773160-0EE6468A-5C37-4497-9DA6-6E888D02F70F

P304

Q26773160-9BE2C302-CCE8-41AC-9D0A-B20759E276F4

P31

Q26773160-6987428F-0CA8-4B8E-BF99-EBD7AF919F50

P3181

Q26773160-4E4883B2-86DC-481F-852E-E6CE510DB2A0

P356

Q26773160-08D2F674-C01C-468D-971F-9CEDC02F346D

P407

Q26773160-5CF54DC1-8D14-43C0-99DC-1733809CAC98

P478

Q26773160-86A6D08B-948A-4334-B7CF-9D0C66523B6B

P50

Q26773160-4B3DB6B7-85AB-424C-8CBA-FA9303DDF918

P577

Q26773160-41FF6189-3732-41A2-8500-3C255A779938

P5875

Q26773160-3FB80A47-1401-488D-90E5-BA58E896D234

P698

Q26773160-E101A973-4F91-4C12-BA9A-6D4A0BDC880B

P921

Q26773160-F8065A3F-B9F4-4459-B4A8-557F8B66D6C4

P932

Q26773160-7854C3E9-8FEE-423C-ACCA-4A346DA520E7

P3181

P356

FPHAR.2015.00286

P1433

Frontiers in Pharmacology

P1476

Advances and Challenges of Liposome Assisted Drug Delivery

@en

P2093

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Lisa Sercombe

http://www.w3.org/2001/XMLSchema#string

Sherry Y Wu

http://www.w3.org/2001/XMLSchema#string

Susan Hua

http://www.w3.org/2001/XMLSchema#string

Tejaswi Veerati

http://www.w3.org/2001/XMLSchema#string

P2860

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

Openings between defective endothelial cells explain tumor vessel leakiness

Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems

Intestinal barrier in inflammatory bowel disease

Liposomes as nanomedical devices

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

Drug delivery systems: entering the mainstream

A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer.

Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.

P304

286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

481401

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FPHAR.2015.00286

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Fatemeh Moheimani

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285573036

http://www.w3.org/2001/XMLSchema#string

P698

26648870

http://www.w3.org/2001/XMLSchema#string

P921

P932

4664963

http://www.w3.org/2001/XMLSchema#string